Literature DB >> 4368392

Alkaline isomerization of ferricytochrome c: identification of the lysine ligand.

H Wilgus, E Stellwagen.   

Abstract

Changes in the visible absorbance spectra of complexes of horse heart cytochrome c hemopeptide 1-65, peptide 66-104, and their guanidinated counterparts are compared with those characteristic of native and fully guanidinated ferricytochrome c over the pH range 7 to 11. Upon raising the pH, the methionine ligand in the guanidinated hemopeptide 1-65.peptide 66-104 complex is replaced by a strong field ligand. By contrast, the methionine ligand in the hemopeptide 1-65.guanidinated peptide 66-104 is replaced by a weak field ligand. These results demonstrate that lysine 13 does not ligate with the heme iron upon isomerization of ferricytochrome c and that the ligand in the horse heart protein is one of the eight lysine residues in the 66-104 segment of the polypeptide, most likely lysine 79.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4368392      PMCID: PMC388578          DOI: 10.1073/pnas.71.7.2892

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Structural bases for function in cytochromes c. An interpretation of comparative x-ray and biochemical data.

Authors:  F R Salemme; J Kraut; M D Kamen
Journal:  J Biol Chem       Date:  1973-11-25       Impact factor: 5.157

2.  The appearance of transient species of cytochrome c upon rapid oxidation or reduction at alkaline pH.

Authors:  D O Lambeth; K L Campbell; R Zand; G Palmer
Journal:  J Biol Chem       Date:  1973-12-10       Impact factor: 5.157

3.  The electron paramagnetic resonance spectrum of ferricytochrome c and lysine-modified derivatives at alkaline pH.

Authors:  R A Morton
Journal:  Can J Biochem       Date:  1973-04

4.  The properties and amino-acid sequence of cytochrome c from Euglena gracilis.

Authors:  D M Lin; R L Niece; W M Fitch
Journal:  Nature       Date:  1973-02-23       Impact factor: 49.962

5.  Alkylation of cytochromes c. I. Properties of alkylated beef cytochrome c.

Authors:  K Ando; H Matsubara; K Okunuki
Journal:  Biochim Biophys Acta       Date:  1966-05-05

6.  Some aspects of pH and temperature dependence of the NMR spectra of cytochrome C.

Authors:  R K Gupta; S H Koenig
Journal:  Biochem Biophys Res Commun       Date:  1971-12-03       Impact factor: 3.575

7.  Carboxymethylation of horse heart ferricytochrome c and cyanferricytochrome c.

Authors:  E Stellwagen
Journal:  Biochemistry       Date:  1968-07       Impact factor: 3.162

8.  The effects of alkylation of methionyl residues on the properties of horse cytochrome c.

Authors:  A Schejter; I Aviram
Journal:  J Biol Chem       Date:  1970-04-10       Impact factor: 5.157

9.  Ferricytochrome c. I. General features of the horse and bonito proteins at 2.8 A resolution.

Authors:  R E Dickerson; T Takano; D Eisenberg; O B Kallai; L Samson; A Cooper; E Margoliash
Journal:  J Biol Chem       Date:  1971-03-10       Impact factor: 5.157

10.  Reconstitution of horse heart cytochrome c: interaction of the components obtained upon cleavage of the peptide bond following methionine residue 65.

Authors:  G Corradin; H A Harbury
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

View more
  3 in total

1.  Physicochemical properties of two atypical cytochromes c, Crithidia cytochrome c-557 and Euglena cytochrome c-558.

Authors:  G W Pettigrew; I Aviram; A Schejter
Journal:  Biochem J       Date:  1975-07       Impact factor: 3.857

2.  Identification of the ligand-exchange process in the alkaline transition of horse heart cytochrome c.

Authors:  P M Gadsby; J Peterson; N Foote; C Greenwood; A J Thomson
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

3.  Modulation of the alkaline transition in cytochrome c and cytochrome c-T by full or specific partial acetimidylation.

Authors:  C J Wallace
Journal:  Biochem J       Date:  1984-02-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.